ArticleScientific reports2022

FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models.

Marie O'Farrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.